• CELLS | Musculoskeletal 2016: Post-Conference Resources

    CELLS | Musculoskeletal 2016: Post-Conference Resources

    We would like to thank those who attended our recent CELLS | Musculoskeletal 2016 conference. You came from over twenty countries and various specialties to experience a highly scientific, yet clinically-relevant program that was excellently delivered by the prestigious faculty. We hope it has furthered interests in regenerative medicine, introduced all to a strong international network and elucidated pathways for clinical translation. 

    On our new event website, a select number of speaker presentations have been made available for download for a one-time fee of $250. You are invited to review the available content prior to purchase, which include PDF versions of the delivered Powerpoints, and companion audio recordings of their live delivery. Presentation access is free for those who attended, please refer to our post-conference email for your username and password details.

    The event is but a stepping stone towards true translation. For those who wish to continue the dialogue, we further encourage reaching out to us directly at info@rgnmed.com. We would be happy to provide next steps towards the establishment of regenerative medicine capabilities at your home clinic, hospital or laboratory.

    Read more →

  • Save the Date: CELLS 2016

    Save the date for this year’s CELLS conference, to be held in Amsterdam, October 7-9.  Event to be hosted at the 5 Star NH Grand Hotel Krasnapolsky, located squarely in the city center of bustling Amsterdam. Stand by for additional conference details, including: clinically relevant conference program download, diverse speaker list announcement and a memorable gala dinner invitation.

    Read more →
  • Gold Winner: CELLS 2015 Abstract Submissions Contest

    Non-Reconstructable Peripheral Vascular Disease of the Lower Extremity in Ten Patients Treated With Adipose-derived Stromal Vascular Fraction Cells:  SVF cell therapy for end-stage disease
    Submitted by: Michael Carstens, M.D., Diego Correa, M.D., Ph.D., Arturo Gomez, M.D., Ronald Cortés, M.D., Elizabeth Turner, M.D., Cecilia Pérez, M.D., Marlon Ocon, M.D.

    Read more →
  • Gold Winner: Osteoplastic Cell-Based Therapy For Delayed Union Fractures

    “A pilot Phase I/IIa, multicentre, open proof-of-concept study on the efficacy and safety of allogeneic osteoblastic cells (ALLOB®) implantation in non-infected delayed-union fractures”

    Elisa Llinares, PhD ; Audrey Colliou, PharmD ; Enrico Bastianelli, MD, MBA

    Read more →
  • Silver Winner: CELLS 2015 Abstract Submissions Contest

    Dzmitry Bukach M.D., Minsk, Belarus


    Current cell therapy for cartilage regeneration has no common approach for stem cells source selection, surgical method of transplantation, cells graft differentiation degree. The objective of the study was to determine the optimal conditions of developed mesenchymal stem cells (MSC) transplantation method in experiment and to analyze its effectiveness and safety in clinical trial.

    Read more →